PPT-Glycemic Management in Type 2 Diabetes

Efficacy and Safety of Modern Antihyperglycemic Therapies 1 DPP4 Inhibitors 2 DPP4 Inhibitors FDAApproved Agents Alogliptin Linagliptin Saxagliptin Sitagliptin Key Features Oral administration. 1. AACE Comprehensive Care Plan. 2. Handelsman Y, et al. . Endocr Pract. . 2011;17(suppl 2):1-53.. Glycemic Management in Type 2 Diabetes. Therapeutic Lifestyle Change. 3. Components of Therapeutic Lifestyle Change. Pregnancy. Chapter 36. David Thompson, Howard Berger,. Denice Feig, Robert Gagnon, Tina Kader,. Erin Keely, Sharon Kozak, Edmond Ryan,. Mathew Sermer, Christina Vinokuroff. In collaboration with …. Monitoring for Glycemic Control. Chapter 9. Lori Berard, Ian Blumer, Robyn Houlden, David Miller, Vincent Woo. Key Messages. Glycated hemoglobin (. A1C. ) .  . measure every 3 months . (6 months if stable at target). Efficacy and Safety of Antihyperglycemic Therapies Introduced Since 2004. 1. *. P. <0.001 vs active comparator monotherapy. . †. P. <0.001 vs active comparator dual therapy.. 1. Nauck MA, et al. . Efficacy and Safety of Antihyperglycemic Therapies Introduced Since 2004. 1. DPP-4 Inhibitors. 2. FDA-Approved Agents. Alogliptin. Linagliptin. Saxagliptin. Sitagliptin. Key Features. Oral administration. Glimepiride, Metformin & . Voglibose. Combination in T2DM. Dr. Mohammed Riyaz . M.D (Medicine), Masters . in . Endocrinology(UK). Chief . Endocrinologist. & Medical Director (EDSC). Type 2 diabetes population requiring stringent . 1. AACE Comprehensive Care Plan. Handelsman YH, et al. . Endocr Pract. . 2015;21(suppl 1):1-87.. 2. Therapeutic Lifestyle Change. Glycemic Management of Type 2 Diabetes. 3. Components of Therapeutic Lifestyle Change. 1. AACE Comprehensive Care Plan. Handelsman YH, et al. . Endocr Pract. . 2015;21(suppl 1):1-87.. 2. Therapeutic Lifestyle Change. Glycemic Management of Type 2 Diabetes. 3. Components of Therapeutic Lifestyle Change. Permission is required from the Association for any commercial use or for reproduction in any print materials. (contact . permissions@diabetes.org) . Standards of Medical Care in Diabetes - 2018. Standards of Care. National Center for Health in Public Housing Clinical Quality Working Group. Diabetes in PHPC Settings. HBA1c>9 in PHPC Settings. American Diabetes Association’s Press Release. The ADA has long recommended that treatment goals be individualized based on factors both modifiable and nonmodifiable, such as age, life expectancy, duration of disease, resources and support, and comorbid conditions. The ADA recommends that a reasonable A1C goal for many nonpregnant adults with type 2 diabetes is less than 7 percent based on the available evidence to date from the ACCORD, ADVANCE, VADT and UKPDS international clinical trials, which were evaluated and incorporated into ADA’s Standards of Care. . STANDARDS OF MEDICAL CARE IN DIABETES - 2019 Guidelines Update Ann Marie Blair, DNP, FNP, NP - C, BC - ADM, CDE Piedmont Columbus Regional Presenter Financial Relationships Disclosure Ann M. Blair, : Long-term hyperglycemia promotes development of complications and suboptimal well-being in patients with diabetes. A stringent glycemic control is a worldwide standard of diabetes care recommended i ●. . Section . was . renamed. ●. . . N. ew recommendation. : . using . reliable data . metrics. ●. . . D. iscussion on . the social determinants of . health. ●. . . Te. lemedicine role. Download PDF The Diabetes Loophole™ eBook by Reed Wilson - A detailed program aimed at helping you understand and address your body\'s requirements when experiencing diabetes symptoms.